BKL and Greenberg Traurig advised NeoImmuneTech, Inc. on the deal. NeoImmuneTech, Inc., a US Delaware corporation engaged in the biotech business, successfully consummated its Korean IPO…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
